Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 8 Underperforming Biotech Stocks Being Bought by the Smart Money
8 Underperforming Biotech Stocks Being Bought by the Smart Money
8 Underperforming Biotech Stocks Being Bought by the Smart Money
Submitted by
admin
on September 25, 2011 - 12:55pm
Source:
Seeking Alpha
News Tags:
Amyris
NPS Pharmaceuticals
Targacept
Sequenom
Cadence Pharmaceuticals
Enzon
Dendreon
Incyte
Headline:
8 Underperforming Biotech Stocks Being Bought by the Smart Money
Do Not Allow Advertisers to Use My Personal information
